Differential Copy Number of Chromosomal blaCTX−M−14 in Escherichia coli Sequence Type ST38 from Companion Dogs and Cats
Current Microbiology · 2026
DOI: 10.1007/s00284-026-04792-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Microbiology, 2026. Verfasst von Kai Kobayashi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan. Hauptthemen laut MEDLINE: Escherichia coli, beta-Lactamases, Escherichia coli Infections, Cat Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, The Takeda Science Foundation.
Abstract (Originalsprache)
Extended-spectrum β-lactamase-producing Enterobacterales pose a significant public health threat from a One Health perspective. During an investigation of companion dogs and cats in Tokyo, we isolated seven Escherichia coli sequence type ST38 strains with characteristic genetic structures related to cephalosporin resistance, as identified by genomic analysis. All strains carried one to three copies of blaCTX−M−14 on their chromosomes, with one strain carrying one copy on a plasmid. Among the six strains with only chromosomal copies, a higher copy number correlated with increased resistance to ceftazidime and elevated blaCTX−M−14 expression, whereas the doubling times calculated from growth curves remained unchanged. Continuous passaging in the presence of ceftazidime resulted in increased copy numbers in three of the six strains. Notably, these characteristics closely resembled those reported for E. coli strains isolated from human clinical cases in South Korea. This similarity suggests that the copy number amplification mechanisms in blaCTX−M−14-carrying E. coli are more widespread than previously recognized, extend across international borders, and adapt to diverse ecological niches, including those of companion animals. Given that an increased copy number enhances resistance to antimicrobial pressure, these findings highlight the need for prudent antimicrobial use in veterinary medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan.
- Laboratory of Veterinary Public Health, School of Veterinary Medicine, Faculty of Veterinary Science, Nippon Veterinary and Life Science University, Tokyo, Japan.
- Department of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan. Hiroaki_Kubota@member.metro.tokyo.jp.
- Laboratory of Veterinary Hygiene, Institute of Agriculture, Tokyo University of Agriculture and Technology, Tokyo, Japan.
Förderung
- Japan Society for the Promotion of Science
- The Takeda Science Foundation
Zitieren
APA
Kobayashi, K., Kubota, H., Ariyoshi, T., Suzuki, Y., Mori, K., Suzuki, J., Ochiai, Y., Sadamasu, K., & Chiba, T. (2026). Differential Copy Number of Chromosomal blaCTX−M−14 in Escherichia coli Sequence Type ST38 from Companion Dogs and Cats. Current Microbiology. https://doi.org/10.1007/s00284-026-04792-7
Vancouver
Kobayashi K, Kubota H, Ariyoshi T, Suzuki Y, Mori K, Suzuki J, et al. Differential Copy Number of Chromosomal blaCTX−M−14 in Escherichia coli Sequence Type ST38 from Companion Dogs and Cats. Current Microbiology. 2026. doi:10.1007/s00284-026-04792-7
BibTeX
@article{Kobayashi2026,
author = {Kobayashi, Kai and Kubota, Hiroaki and Ariyoshi, Tsukasa and Suzuki, Yasunori and Mori, Kohji and Suzuki, Jun and Ochiai, Yoshitsugu and Sadamasu, Kenji and Chiba, Takashi},
title = {Differential Copy Number of Chromosomal blaCTX−M−14 in Escherichia coli Sequence Type ST38 from Companion Dogs and Cats},
journal = {Current Microbiology},
year = {2026},
doi = {10.1007/s00284-026-04792-7}
}
EUVIMED